One Step Forward Toward a Surrogate Endpoint for Clinical Trials of Alzheimer's Disease Drugs: The Results of PharmaCog WP5 (European ADNI)

Frisoni, Giovanni; Blin, Olivier; Bordet, Regis

doi:10.3233/JAD-190267

Scientific article

Editorial

English

One Step Forward Toward a Surrogate Endpoint for Clinical Trials of Alzheimer's Disease Drugs: The Results of PharmaCog WP5 (European ADNI)

ContributorsFrisoni, Giovanni; Blin, Olivier; Bordet, Regis

Published inJournal of Alzheimer's Disease, vol. 69, no. 1, p. 1-2

Publication date2019

Affiliation

Faculté de médecine / Section de médecine clinique / Département de réadaptation et gériatrie

Research group

Troubles de mémoire et maladie d'Alzeimer (935)

Citation (ISO format)

FRISONI, Giovanni, BLIN, Olivier, BORDET, Regis. One Step Forward Toward a Surrogate Endpoint for Clinical Trials of Alzheimer’s Disease Drugs: The Results of PharmaCog WP5 (European ADNI). In: Journal of Alzheimer’s Disease, 2019, vol. 69, n° 1, p. 1–2. doi: 10.3233/JAD-190267

Article (Published version)

Identifiers

PID : unige:132434
DOI : 10.3233/JAD-190267
PMID : 30958385

Commercial URLhttps://content.iospress.com/articles/journal-of-alzheimers-disease/jad190267

ISSN of the journal1387-2877

227views

0downloads

Creation05/20/2019 4:20:00 PM

First validation05/20/2019 4:20:00 PM

Update time03/15/2023 9:15:36 PM

Status update03/15/2023 9:15:36 PM

Last indexation01/17/2024 9:12:18 AM

Archive ouverte UNIGE

One Step Forward Toward a Surrogate Endpoint for Clinical Trials of Alzheimer's Disease Drugs: The Results of PharmaCog WP5 (European ADNI)

Technical informations